Maxim downgraded Annovis Bio to Hold from Buy, citing near-term capital needs and the view that the Phase 2/3 Alzheimer data did “not impress.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS: